BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35821038)

  • 21. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
    Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
    Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the expression of IGFBP-1 (insulin-like growth factor binding protein-1) in human endometrial stromal cells.
    Gao J; Mazella J; Tang M; Tseng L
    Mol Endocrinol; 2000 Dec; 14(12):1954-61. PubMed ID: 11117526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
    Diep CH; Ahrendt H; Lange CA
    Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle.
    Boonyaratanakornkit V; McGowan E; Sherman L; Mancini MA; Cheskis BJ; Edwards DP
    Mol Endocrinol; 2007 Feb; 21(2):359-75. PubMed ID: 17138644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
    Faivre E; Skildum A; Pierson-Mullany L; Lange CA
    Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
    Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
    Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
    Wu J; Brandt S; Hyder SM
    Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
    Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
    Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity.
    Richer JK; Lange CA; Manning NG; Owen G; Powell R; Horwitz KB
    J Biol Chem; 1998 Nov; 273(47):31317-26. PubMed ID: 9813040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of progesterone in endometrial cancer.
    Kim JJ; Chapman-Davis E
    Semin Reprod Med; 2010 Jan; 28(1):81-90. PubMed ID: 20104432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective and opposing actions of progesterone receptor isoforms in human endometrial stromal cells.
    Yudt MR; Berrodin TJ; Jelinsky SA; Hanna LA; Brown EL; Chippari S; Bhat RA; Winneker RC; Zhang Z
    Mol Cell Endocrinol; 2006 Mar; 247(1-2):116-26. PubMed ID: 16442706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromatin topology defines estradiol-primed progesterone receptor and PAX2 binding in endometrial cancer cells.
    La Greca A; Bellora N; Le Dily F; Jara R; Nacht AS; Quilez Oliete J; Villanueva JL; Vidal E; Merino G; Fresno C; Tarifa Reischle I; Vallejo G; Vicent G; Fernández E; Beato M; Saragüeta P
    Elife; 2022 Jan; 11():. PubMed ID: 35018885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Met909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins.
    Petit-Topin I; Turque N; Fagart J; Fay M; Ulmann A; Gainer E; Rafestin-Oblin ME
    Mol Pharmacol; 2009 Jun; 75(6):1317-24. PubMed ID: 19289570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases.
    Boonyaratanakornkit V; Scott MP; Ribon V; Sherman L; Anderson SM; Maller JL; Miller WT; Edwards DP
    Mol Cell; 2001 Aug; 8(2):269-80. PubMed ID: 11545730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
    Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
    Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway.
    Ai Z; Wang J; Wang Y; Lu L; Tong J; Teng Y
    Cancer; 2010 Aug; 116(15):3603-13. PubMed ID: 20564127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer.
    Kavlashvili T; Jia Y; Dai D; Meng X; Thiel KW; Leslie KK; Yang S
    PLoS One; 2016; 11(2):e0148912. PubMed ID: 26859414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events.
    Charles NJ; Thomas P; Lange CA
    Horm Cancer; 2010 Aug; 1(4):167-76. PubMed ID: 21761364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin.
    Lessey BA; Ilesanmi AO; Castelbaum AJ; Yuan L; Somkuti SG; Chwalisz K; Satyaswaroop PG
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):31-9. PubMed ID: 9009235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.